• Wed news: 2025 Medicare drug price negotiations. BioAge Labs aiming at $180M IPO. Merck Keytruda colorectal cancer flop. Sanofi gets bids for consumer health unit. Novo Nordisk CEO in Senate hot seat. See more on our front page

Tribal deal shot down in courts


<



The loss of exclusivity is already built in, in the stock price, but there will be a dip. People will ask for Saunders to quit. His stupidity is to blame for this PR fiasco. Saunders and his boys, will probably now have to spinoff the aesthetics division...